New Global Alliance To Drive Momentum On Decentralized Trials
The Coronavirus Pandemic Is Forcing A Shift In Attitude
A new multi-stakeholder alliance wants to improve the adoption of decentralized clinical trials that have already drawn much attention during the COVID-19 pandemic. There are plans to aggregate best practices, share evidence and information, and identify and address key barriers.
You may also be interested in...
The French company is promoting its ScanWatch as the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist.
The Association of Contract Research Organizations’ revised toolkit on decentralized trials explains how to deal with data quality and integrity.
The Danish medicines regulator has set out its expectations on key elements of decentralized clinical trials as part of Denmark’s ongoing effort to develop a robust regulatory framework in this area.